Clinical Trials Directory

Trials / Completed

CompletedNCT03269747

Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Interventional, Placebo controlled cross-over study to investigate the short-term effects of glucocorticoids (prednisone) on human brown adipose tissue.

Detailed description

Active brown adipose tissue (BAT) has recently been unambiguously discovered in human adults. Active BAT increases energy expenditure and improves glucose tolerance. Pharmacological use of glucocorticoids (GCs) is widespread in clinical practice due to their high anti-inflammatory efficacy. While short-term administration even of high doses usually is well tolerated, long-term use of medium to high amounts of GCs leads to unfavorable metabolic changes, characterized by an increase in intra-abdominal fat mass, a decrease in muscle mass and insulin resistance. In line with these well-known side-effects of GCs, several in vitro studies and animal models demonstrate an inhibiting effect of GCs on BAT thermogenesis.

Conditions

Interventions

TypeNameDescription
DRUGPrednisone2 tablets of Prednisone 20 Mg in the morning
DRUGPlacebo2 Placebo tablets in the morning

Timeline

Start date
2017-12-06
Primary completion
2019-04-16
Completion
2019-04-16
First posted
2017-09-01
Last updated
2019-06-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03269747. Inclusion in this directory is not an endorsement.